Literature DB >> 12466240

Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.

R Pedrosa1, P Soares-da-Silva.   

Abstract

1. The present study was designed to evaluate the nature of intervening agents in L-DOPA- and dopamine-induced neurotoxicity in Neuro-2A cells. 2. In the absence of cells and in conditions of light protection, at 37 degrees C, L-DOPA or dopamine (1 mM) in culture medium degraded spontaneously in a time-dependent manner, this being prevented by ascorbic acid (200 microM) and other antioxidants, namely glutathione (1 mM), N-acetyl-L-cysteine (1 mM), sodium metabisulphite (200 microM), but not N-ter-butyl-alpha-phenylnitrone (1 mM) and deferoxamine (100 microM). 3. The viability of Neuro-2A cells declined following treatment with L-DOPA or dopamine in a concentration- and time-dependent manner. The decrease in cell viability by L-DOPA (10+/-4% of control) or dopamine (15+/-4% of control) was markedly attenuated by antioxidants (ascorbic acid, glutathione, N-acetyl-L-cysteine and sodium metabisulphite). Autoxidation of L-DOPA or dopamine was accompanied by the formation of H(2)O(2) in a time-dependent manner, this being completely prevented by ascorbic acid at 24 h or markedly reduced at 48 h. 4. Protective effects of 100 U ml(-1) catalase (40+/-1% of control) against L-DOPA-induced cell death were lower than those conferred by 200 microM ascorbic acid (70+/-3% of control). Catalase-induced protection (59+/-5% of control) against dopamine-induced cell death was similar to that conferred by 200 microM ascorbic acid (57+/-4% of control). L-DOPA-induced neuronal cell death was also accompanied by increases in caspase-3 activity, this being insensitive to ascorbic acid. Dopamine-induced increase in caspase-3 activity occurred only when autoxidation of the amine was prevented by ascorbic acid. 5. It is suggested that in addition to generation of H(2)O(2) and quinone formation, L-DOPA- and dopamine-induced cell death may result from induction of apoptosis, as evidenced by increases in caspase-3 activity. Dopamine per se induces apoptosis by a mechanism independent of oxidative stress, as evidenced by the fact that increases in caspase-3 activity occurred only when autoxidation of the amine was prevented.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466240      PMCID: PMC1573607          DOI: 10.1038/sj.bjp.0704982

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Evidence for non-oxidative dopamine cytotoxicity: potent activation of NF-kappa B and lack of protection by anti-oxidants.

Authors:  P Weingarten; J Bermak; Q Y Zhou
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

2.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

Authors:  A Hartmann; S Hunot; P P Michel; M P Muriel; S Vyas; B A Faucheux; A Mouatt-Prigent; H Turmel; A Srinivasan; M Ruberg; G I Evan; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Regulatory pathways and uptake of L-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells.

Authors:  B Sampaio-Maia; M P Serrão; P Soares-da-Silva
Journal:  Am J Physiol Cell Physiol       Date:  2001-02       Impact factor: 4.249

Review 4.  Glutathione, oxidative stress and neurodegeneration.

Authors:  J B Schulz; J Lindenau; J Seyfried; J Dichgans
Journal:  Eur J Biochem       Date:  2000-08

Review 5.  The role of iron in the initiation of lipid peroxidation.

Authors:  G Minotti; S D Aust
Journal:  Chem Phys Lipids       Date:  1987 Jul-Sep       Impact factor: 3.329

6.  Uptake and binding of dopamine and 6-hydroxydopamine in murine neuroblastoma and fibroblast cells.

Authors:  A Rotman; J W Daly; C R Creveling; X O Breakefield
Journal:  Biochem Pharmacol       Date:  1976-02-15       Impact factor: 5.858

7.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

8.  Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.

Authors:  D G Graham
Journal:  Mol Pharmacol       Date:  1978-07       Impact factor: 4.436

9.  The neurochemistry of Parkinson's disease: effect of L-dopa therapy.

Authors:  K G Lloyd; L Davidson; O Hornykiewicz
Journal:  J Pharmacol Exp Ther       Date:  1975-12       Impact factor: 4.030

Review 10.  The evolution and origin of motor complications in Parkinson's disease.

Authors:  J A Obeso; M C Rodriguez-Oroz; P Chana; G Lera; M Rodriguez; C W Olanow
Journal:  Neurology       Date:  2000       Impact factor: 9.910

View more
  32 in total

1.  L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  Neuropharmacology       Date:  2012-11-27       Impact factor: 5.250

2.  National Institute on Drug Abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.

Authors:  Vishnudutt Purohit; Rao Rapaka; Jerry Frankenheim; Albert Avila; Roger Sorensen; Joni Rutter
Journal:  J Neurovirol       Date:  2013-03-01       Impact factor: 2.643

3.  Signaling of short- and long-term regulation of intestinal epithelial type 1 Na+/H+ exchanger by interferon-gamma.

Authors:  Fernando Magro; Sónia Fraga; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 4.  Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability.

Authors:  Roberto Rodrigues; Robert B Petersen; George Perry
Journal:  Cell Mol Neurobiol       Date:  2014-06-14       Impact factor: 5.046

5.  Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.

Authors:  G Gille; K Radad; H Reichmann; W-D Rausch
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 6.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

7.  Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis.

Authors:  Tina M Calderon; Dionna W Williams; Lillie Lopez; Eliseo A Eugenin; Laura Cheney; Peter J Gaskill; Mike Veenstra; Kathryn Anastos; Susan Morgello; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2017-01-29       Impact factor: 4.147

Review 8.  Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.

Authors:  Vishnudutt Purohit; Rao Rapaka; David Shurtleff
Journal:  Mol Neurobiol       Date:  2011-07-01       Impact factor: 5.590

9.  Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse.

Authors:  Peter J Gaskill; Tina M Calderon; Aimée J Luers; Eliseo A Eugenin; Jonathan A Javitch; Joan W Berman
Journal:  Am J Pathol       Date:  2009-08-06       Impact factor: 4.307

10.  Protective effects of Althaea officinalis L. extract in 6-hydroxydopamine-induced hemi-Parkinsonism model: behavioral, biochemical and histochemical evidence.

Authors:  Maryam Rezaei; Masoud Alirezaei
Journal:  J Physiol Sci       Date:  2014-01-25       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.